Adicet Bio, Inc. Payments for Restructuring
Adicet Bio, Inc. (ACET) reported Payments for Restructuring of $500.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2020-05-07
- Adicet Bio, Inc. payments for restructuring for the quarter ending 2020-03-31 was $500.00K.
- Adicet Bio, Inc. payments for restructuring for the quarter ending 2019-12-31 was $66.00K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month |
|---|---|---|
| 2020-03-31 | $500.00K 10-Q · filed 2020-05-07 | $566.00K derived: sum of 2 quarters · filed 2020-05-07 |
| 2019-12-31 | $66.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |